TD
Translational Development Acquisition Corp.
TDACW · NASDAQ
$1.45 +346.15% (+$1.13)
1M -9.09%
Market Cap $38.2M
P/E Ratio 6.90x
Div. Yield -
ROE 3.28%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/E 6.90x
P/B 0.26x
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
36 /100
Average ROE 3.28%
ROA 3.52%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.06x
Debt/Equity N/A
Int. coverage N/A
Stability
0 /100
Unstable Beta 2.11x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o TDACW
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Michael Hoffman
Employees
2
Headquarters
New York City